K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

Acronyms and Abbreviations

AASK African American Study of Kidney Disease and Hypertension
ABCD Appropriate Blood Pressure Control in Diabetes
ABPM ambulatory blood pressure monitoring
ACE angiotensin-converting enzyme
ACE-I angiotensin-converting enzyme inhibitor
ADA American Diabetes Association
AGEs advanced glycation end-products
AHA American Heart Association
AHRQ Agency for Healthcare Research and Quality
AIPRD ACE Inhibition in Progressive Renal Disease
AIPRI ACE Inhibition in Progressive Renal Insufficiency
AJKD American Journal of Kidney Diseases
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
ANBP2 Second Australian National Blood Pressure Study
ARB angiotensin-receptor blocker
ARIC Atherosclerosis Risk in Communities
ASCVD atherosclerotic cardiovascular disease
BMI body mass index
BSA body surface area
BUN blood urea nitrogen
CABG coronary artery bypass graft
CAPP Captopril Prevention Project
CARI Caring for Australians with Renal Impairment
CBP casual blood pressure
CCB calcium-channel blocker
Ccr creatinine clearance
CHF congestive heart failure
CKD chronic kidney disease
CMS Center for Medicare and Medicaid Services
CONVINCE Controlled Onset Verapamil Investigation of Cardiovascular Endpoints
COX2 cyclo-oxygenase type 2
CTA computerized tomographic angiography
CVD cardiovascular disease
DASH Dietary Approaches to Stop Hypertension
DAVIT Danish Verapamil Infarction Trial
DBP diastolic blood pressure
DEXA dual energy x-ray absorptiometry
DM diabetes mellitus
DOQI Dialysis Outcomes Quality Initiative
ECF extracellular fluid
EEG Electroencephalogram
EPHESUS Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
ESRD end-stage renal disease
FACET Fosinopril Amlodipine Cardiovascular Events Trial
GABA gamma-hydroxybutyric acid
GFR glomerular filtration rate
GITS Gastrointestinal Therapeutic System
GP general population
HARVEST Hypertension and Ambulatory Recording Venetia Study
HCTZ Hydrochlorothiazide
HOPE Heart Outcomes Prevention Evaluation
ICSI Institute for Clinical Systems Improvement
IDNT Irbesartan Diabetic Nephropathy Trial
IHD ischemic heart disease
INSIGHT Intervention as a Goal in Hypertension Treatment
INVEST International Verapamil SR/Trandolapril Study
ISA intrinsic sympathomimetic activity
JNC Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
KDOQI Kidney Disease Outcomes Quality Initiative
LIFE Losartan Intervention for Endpoint Reduction
LVH left ventricular hypertrophy
MAP mean arterial pressure
MDRD Modification of Diet in Renal Disease
MI myocardial infarction
MNT Medical Nutrition Therapy
MRA magnetic resonance angiography
NCHS National Center for Health Statistics
NHANES III Third National Health and Nutrition Examination Survey
NHBPEP National High Blood Pressure Educational Program
NHLBI National Heart, Lung, and Blood Institute
NKF National Kidney Foundation
NORDIL Nordic Diltiazem
NSAID Nonsteroidal anti-inflammatory agent
NYHA New York Heart Association
PGC intra-glomerular pressure
PKD polycystic kidney disease
PRA plasma renin activity
PREVEND Prevention of Renal and Vascular End Stage Disease
PTRA percutaneous transluminal renal angioplasty
PVD peripheral vascular disease
QA single nephron blood flow
RA afferent arteriolar resistance
RAD renal artery disease
RALES Randomized Aldactone Evaluation Study
RAS renin-angiotensin system
RCT randomized controlled trial
RDA recommended daily allowance
RE efferent arteriolar resistance
REIN Ramipril Efficacy in Nephropathy
RENAAL Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan
ROC receiver operator curves
RVHT renovascular hypertension
SBP systolic blood pressure
Scr serum creatinine concentration
SD standard deviation
SGA subjective global assessment
SIGN Scottish Intercollegiate Guidelines Network
SMBP self-measured blood pressure
SNGFR single-nephron GFR
SNP single nucleotide polymorphism
Syst-China Systolic Hypertension in China
Syst-Eur Systolic Hypertension in Europe
TIA transient ischemic attack
UAC urinary albumin concentration
USRDS United States Renal Data System
WCH white-coat hypertension